2021

Record of Committee Proceedings

Joint Committee for Review of Administrative Rules

Clearinghouse Rule 20-080

Relating to designating Gabapentin as a monitored drug having a substantial potential for abuse.

Submitted by Controlled Substances Board

May 12, 2021              Referred to Joint Committee for Review of Administrative Rules

June 18, 2021              no action taken

______________________________

Adam Field

Committee Clerk